Using QuantiFERON-TB Gold as the sole screening test before starting biologic therapy reduces TB diagnoses compared with ...

Due to the poor positive predictive value of nucleic acid amplification tests (NAATs) for gonorrhoea when applied to a low-prevalence setting, current guidelines recommend the use of supplementary ...

SmartQR Technologies has revolutionized healthcare diagnostics in India with AI-driven solutions, enhancing access, and ...

A smart DNA-targeting test detects tuberculosis from tongue swabs with 74% sensitivity, providing a painless option to normal ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough ...

ProteCoat™ is a non-toxic antimicrobial coating technology developed by Reactive Surfaces aimed at reducing healthcare-associated infections (HAIs) in hospitals and public spaces ...

HPV cfDNA is a highly effective tumor marker for monitoring disease progression and treatment response in HPV-positive cervical cancer, offering valuable insights for guiding clinical decisions in ...

The firm acquired intellectual property from Mammoth Biosciences that will reduce the speed and cost of its in-development point-of-care solution.

The company plans to raise money this fall to support the continued development of its head-and-neck cancer testing platform and oral squamous cell carcinoma test.